Gary S. Gillheeney sold $212k of ORGO
President and CEO at Organogenesis Holdings Inc.. 59,468 shares at an average of $3.56, traded Dec 6, 2024, filed Dec 9, 2024.
Score components
- +25RoleCEO
- +12Trade size$212k at market
- 0Share of holdings soldSold 1.7% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.6%, 3m +46.6%, 6m -1.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-24-020285, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 5, 2024 | MOption exercise Class A Common Stock | +1,067,245 | $0.99 | $1.1M | 3,419,194 | Dec 9, 2024 |
| Dec 6, 2024 | SOpen-market sale Class A Common Stock | -18,416 | $3.65 | $67k | 3,400,778 | Dec 9, 2024 |
| Dec 9, 2024 | SOpen-market sale Class A Common Stock | -41,052 | $3.52 | $145k | 3,359,726 | Dec 9, 2024 |
| Dec 5, 2024 | MOption exercise Stock Option (Right to Buy)derivative | -1,067,245 | $0.00 | $0 | 0 | Dec 9, 2024 |
Related signals
Other insiders at Organogenesis Holdings Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | Organogenesis Holdings Inc. | Michael Joseph Driscoll director | $27k 10,000 shares | +5% | |
| 41Moderate | Organogenesis Holdings Inc. | Arthur S Leibowitz director | $13k 5,000 shares | +2% | |
| 40Moderate | ORGOsell Organogenesis Holdings Inc. | Glenn H Nussdorf director | $1.0M 200,000 shares | -7% | |
| 40Moderate | ORGOsell Organogenesis Holdings Inc. | Glenn H Nussdorf director, owner | $1.6M 300,000 shares | -10% | |
| 56Moderate | ORGObuy Organogenesis Holdings Inc. | Glenn H Nussdorf director, owner | $1.1M 358,495 shares | - | |
| 24Weak | ORGOsell Organogenesis Holdings Inc. | Glenn H Nussdorf director, owner | $81k 22,776 shares | -6% | |
| 50Moderate | ORGObuy Organogenesis Holdings Inc. | Lori Freedman Chief Admin. and Legal Officer | $725k 252,264 shares | +42% | |
| 31Weak | ORGOsell Organogenesis Holdings Inc. | Michael Joseph Driscoll director | $128k 25,000 shares | -13% | |
| 37Weak | ORGOsell Organogenesis Holdings Inc. | Gary S. Gillheeney President and CEO | $206k 61,200 shares | -2% | |
| 49Moderate | ORGOsell Organogenesis Holdings Inc. | Gary S. Gillheeney President and CEO | $940k 259,332 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.